- 专利标题: PTGDR-1 and/or PTGDR-2 antagonists for preventing and/or treating systemic lupus erythematosus
-
申请号: US16846611申请日: 2020-04-13
-
公开(公告)号: US11559513B2公开(公告)日: 2023-01-24
- 发明人: Nicolas Charles , Christophe Pellefigues
- 申请人: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , UNIVERSITÉ PARIS DIDEROT—PARIS 7
- 申请人地址: FR Paris; FR Paris
- 专利权人: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITÉ PARIS DIDEROT—PARIS 7
- 当前专利权人: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITÉ PARIS DIDEROT—PARIS 7
- 当前专利权人地址: FR Paris; FR Paris
- 优先权: EP15305222 20150213
- 主分类号: A61K31/403
- IPC分类号: A61K31/403
摘要:
The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.